United Therapeutics Corporation (UTHR)

Healthcare · Pharmaceuticals · Price $527.91
Updated: Aug 28, 2026
Net Income (TTM)
$1.3B
Trailing 12 Months
Growth Rate
17.35%
Log-Linear Regression (16Q)
Price/Earnings
18.9x
Valuation Multiple
EPS (Diluted)
$27.91
Net Income / Shares
Net Margin
41.56%
Profitability

📈 Net Income History (16 Quarters)

🧮 UTHR Net Income Breakdown

Net Income = Revenue - All Expenses - Taxes - Interest
Revenue (Top Line) $3.2B
Less: Cost of Revenue → Gross Profit $2.7B
Less: Operating Expenses → Operating Income $1.4B
Less: Interest Expense $12.0M
Less: Income Tax Expense $262.1M
Equals: Net Income (Bottom Line) $1.3B

Understanding Net Income

Net income, also called the "bottom line" or net profit, is the money a company keeps after paying all expenses including cost of goods, operating costs, interest, and taxes. For UTHR, the trailing twelve month net income is $1.3B.

Why Net Income Matters

Net income is the ultimate measure of accounting profitability. It determines earnings per share (EPS), affects stock valuations through the P/E ratio, and represents the theoretical amount available to shareholders. However, net income can be influenced by accounting choices, which is why value investors often look at cash flow metrics alongside it.

UTHR's net income growth rate of 17.35% (based on log-linear regression of 16 quarters) indicates strong profit growth above market averages.

Net Income vs Cash Flow Metrics

Free Cash Flow: $1.0B →

Actual cash generated after capital expenditures. FCF often differs from net income due to depreciation, working capital changes, and capex timing.

Owner Earnings: $1.5B →

Buffett's preferred metric that adds back depreciation but subtracts maintenance capex. Often considered more accurate than net income.

EPS (Diluted): $27.91 →

Net income divided by diluted shares outstanding. The primary driver of the P/E ratio used in valuations.

Revenue: $3.2B →

The top line that net income is derived from. Net margin shows what percentage of revenue becomes profit.

P/E Ratio Analysis

UTHR's P/E ratio of 18.9x means investors pay $18.91 for every $1 of annual earnings. A P/E between 15-25 is average for the market, reflecting moderate growth expectations.

Net Margin: Profitability Efficiency

Net margin of 41.56% shows what percentage of UTHR's revenue converts to profit after all costs. Net margins above 20% are excellent and indicate strong pricing power or asset-light business models.

Summary: UTHR Net Income Trend

United Therapeutics Corporation (UTHR) has a net margin of 41.56%, which Zyberno classifies as excellent for a Healthcare company — above the 18% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 17.35% annually — above the 10% threshold Zyberno considers healthy growth above market averages. For complete financial analysis, view the full UTHR stock report on Zyberno.

Frequently Asked Questions

What is UTHR's current net income?

United Therapeutics Corporation's TTM net income is $1.3B, growing at 17.35% annually — above the 10% threshold Zyberno considers healthy growth above market averages.

Is UTHR's net income growing?

United Therapeutics Corporation (UTHR) has a net margin of 41.56%, which Zyberno classifies as excellent for a Healthcare company — above the 18% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 17.35% annually — above the 10% threshold Zyberno considers healthy growth above market averages.

What is UTHR's net profit margin?

United Therapeutics Corporation (UTHR) has a net margin of 41.56%, which Zyberno classifies as excellent for a Healthcare company — above the 18% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 17.35% annually — above the 10% threshold Zyberno considers healthy growth above market averages.

What is UTHR's P/E ratio?

UTHR's P/E ratio is 18.9x, meaning the market values the company at 18.9 times its annual earnings.

How does net income differ from free cash flow?

Net income is an accounting measure that includes non-cash items like depreciation, while free cash flow shows actual cash generated. UTHR's net income is $1.3B versus free cash flow of $1.0B. Large differences often indicate significant capital expenditures or working capital changes.

📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
$1,077.36
🛡️
Margin of Safety
Valuation Gap
51.0%
🎯
Expected Return
Projected Annual
38.4%
Click any metric for full methodology and detailed analysis

📊 Full UTHR Stock Report

See UTHR's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

💵 UTHR Free Cash Flow

Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.

💰 UTHR Owner Earnings

Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.

📈 UTHR Earnings Per Share

Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.

🎯 UTHR Earnings Surprise (SUE)

See whether UTHR is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

📊 UTHR Revenue

Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.

💰 UTHR Net Income

Analyze the bottom-line profit, P/E ratio, and net profit margin trends.

🔶 UTHR Operating Income

Analyze EBIT, operating margin, and core business profitability before interest and taxes.

💜 UTHR Gross Profit

Analyze gross margin, pricing power, and profitability before operating expenses.

View Full UTHR Report Find More Quality Stocks
Scroll to Top